1)Cancer Statistics in Japan 2014. p.1-115. http://www.fpcr.or.jp
|
|
|
2)日本肺癌学会,編.臨床・病理肺癌取扱い規約.第7版.金原出版;2010. p. 3-116
|
|
|
3)Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Pathology and genetics: tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. Lyon; IARC press: 2004. p.9-76
|
|
|
4)Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995; 75: 2844-52
|
|
|
5)Travis WD, Brambilla E, Noguchi M, et al, International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011; 6: 244-85
|
|
|
6)Travis WD, Brambilla E, Burke AP, et al, eds. World Health Organization classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: International Agency for Research on Cancer; 2015
|
|
|
7)Minami Y, Matsuno Y, Iijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer. 2005; 48: 339-48
|
|
|
8)Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer. 2001; 33: 17-25
|
|
|
9)Higashiyama M, Kodama K, Yokouchi H, et al. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg. 1999; 68: 2069-73
|
|
|
10)Yim J, Zhu LC, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Modern Pathol. 2007; 20: 233-41
|
|
|
11)Yokose T, Suzuki K, Nagai K, et al. Favorable and unfavorable morphological prognosis factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer. 2000; 29: 179-88
|
|
|
12)Noguchi M. Stepwise progression of pulmonary adenocarcinoma-clinical and molecular implications. Cancer Metastasis Rev. 2010; 29: 15-21
|
|
|
13)Nakazato Y, Maeshima A, Ishikawa Y, et al. Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thoracic Oncol. 2013; 8: 736-43
|
|
|
14)Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 2003; 27: 101-9
|
|
|
15)Amin M, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002; 26: 358-64
|
|
|
16)Kamiya K, Hayashi Y, Douguchi J, et al. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol. 2008; 21: 992-1001
|
|
|
17)Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer. 2013; 81: 371-6
|
|
|
18)Sakuma Y, Matsukuma S, Yoshihara M, et al. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas-Confirmation of the correlations with histologic subtypes and gene mutations. Am J Clin Pathol. 2007; 128: 100-8
|
|
|
19)Kadota K, Yeh Y, D’Angelo S, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma invasive mucinous pattern and extracellular mucin are associated with KRAS mutatin. Am J Surg Pathol. 2014; 38: 1118-27
|
|
|
20)Sugano M, Nagasaka T, Sasaki E, et al. HNF4alpha as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol. 2013; 37: 211-8
|
|
|
21)Tsuta K, Ishii G, Nitadori J, et al. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J Pathol. 2006; 209: 78-87
|
|
|
22)Nakatani Y, Kitamura H, Inayama Y, et al. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol. 1998; 22: 399–411
|
|
|
23)Nakatani Y, Masudo K, Miyagi Y, et al. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol. 2002; 15: 617-24
|
|
|
24)Hatanaka K, Tsuta K, Watanabe K, et al. Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7. Pathol Res Pract. 2011; 207: 188-91
|
|
|
25)Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol. 2008; 3: 13-7
|
|
|
26)Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology. Implication of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification. Arch Pathol Lab Med. 2013; 137: 668-84
|
|
|
27)Montezuma D, Azevedo R, Lopes P, et al. A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens. Virchows Arch. 2013; 463: 749-54
|
|
|
28)Takeuchi T, Tomida S, Yatabe Y, et al. Expression profile–defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopatho-logic behaviors. J Clin Oncol. 2006; 24: 1679-88
|
|
|
29)Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6
|
|
|